Drug Profile
Research programme: cardiovascular disease therapeutics - Evotec SE
Alternative Names: Renin-inhibitors - Evotec SELatest Information Update: 25 Sep 2019
Price :
$50
*
At a glance
- Originator Evotec AG
- Class
- Mechanism of Action Renin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cardiovascular disorders
Most Recent Events
- 25 Sep 2007 Preclinical trials in Cardiovascular disorders in Germany (unspecified route)